Elite Diagnostic Limited

JMSE:ELITE Stock Report

Market Cap: JA$671.5m

Elite Diagnostic Past Earnings Performance

Past criteria checks 4/6

Elite Diagnostic's earnings have been declining at an average annual rate of -11.3%, while the Healthcare industry saw earnings growing at 16.8% annually. Revenues have been growing at an average rate of 15% per year. Elite Diagnostic's return on equity is 4%, and it has net margins of 2.4%.

Key information

-11.3%

Earnings growth rate

-11.7%

EPS growth rate

Healthcare Industry Growth-2.9%
Revenue growth rate15.0%
Return on equity4.0%
Net Margin2.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Elite Diagnostic makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

JMSE:ELITE Revenue, expenses and earnings (JMD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24828203270
30 Jun 24821263130
31 Mar 2476773170
31 Dec 2376402970
30 Sep 2376622850
30 Jun 23755132770
31 Mar 23740182730
31 Dec 22699402550
30 Sep 22669552330
30 Jun 22624492110
31 Mar 22591402080
31 Dec 21559161970
30 Sep 21538121860
30 Jun 2150721750
31 Mar 21458-131570
31 Dec 20440-201580
30 Sep 20432-181500
30 Jun 2044091440
31 Mar 20463481420
31 Dec 19459661350
30 Sep 19437671350
30 Jun 19405521330
31 Mar 19367491220
31 Dec 18338401130
30 Sep 18313361050
30 Jun 1829845890
31 Mar 1830430900
31 Dec 1729142760
30 Sep 1727649650
30 Jun 1726344630
30 Jun 1619429610

Quality Earnings: ELITE has high quality earnings.

Growing Profit Margin: ELITE's current net profit margins (2.4%) are higher than last year (0.3%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: ELITE's earnings have declined by 11.3% per year over the past 5 years.

Accelerating Growth: ELITE's earnings growth over the past year (883.6%) exceeds its 5-year average (-11.3% per year).

Earnings vs Industry: ELITE earnings growth over the past year (883.6%) exceeded the Healthcare industry 15.6%.

Return on Equity

High ROE: ELITE's Return on Equity (4%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 11:38
End of Day Share Price 2024/12/31 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Elite Diagnostic Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution